_asco-gu-2023-prostate-qol-data-and-apalutamide-plus-active-surveillance.jpg "ASCO GU 2023: Prostate QoL data and apalutamide plus active surveillance from gu college study Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 11 min 56 sec
✓ Published: 21-Mar-2023
✓ Published: 21-Mar-2023
Description:
Prof Heather Payne (University College Hospital, London, UK) and Dr Jochen Walz (Institut Paoli-Calmettes Cancer Centre, Marseille, France) discuss the latest quality of life data in prostate cancer. They initially talk about the safety and quality of life analyses of apalutamide plus active surveillance versus active surveillance alone for low, intermediate risk prostate cancer. Prof Payne and Dr Walz then discusses the patient perspective on fatigue and its management for advanced prostate can
Prof Heather Payne (University College Hospital, London, UK) and Dr Jochen Walz (Institut Paoli-Calmettes Cancer Centre, Marseille, France) discuss the latest quality of life data in prostate cancer. They initially talk about the safety and quality of life analyses of apalutamide plus active surveillance versus active surveillance alone for low, intermediate risk prostate cancer. Prof Payne and Dr Walz then discusses the patient perspective on fatigue and its management for advanced prostate can
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
![[+]](/images/menu.gif){kind=small}